14 major changes Viseven witnessed over 14 years in the industry

1. Technological advancements: Now, pharmaceutical companies leverage advanced technologies like artificial intelligence, machine learning, and big data analytics for drug discovery, clinical trials, and commercial activity. Fourteen years ago, these technologies were a lot less integrated.
2. Precision medicine: Today, there's a stronger emphasis on personalized medicine, tailoring treatments to an individual's genetic makeup and health history, leading to more effective and targeted therapies.
3. New markets: Emerging markets and developing countries are becoming more significant players in both drug manufacturing and clinical research.
4. Vaccines: The rapid development and deployment of COVID-19 vaccines showcased the industry's agility and collaboration, a departure from the longer timelines seen 14 years ago.
5. Regulatory changes: Regulatory frameworks have evolved to accommodate new technologies and streamline drug approval processes, fostering innovation and quicker time-to-market compared to 14 years ago.
6. Drug pricing and access: The discussion around drug pricing and accessibility has intensified, leading to increased efforts to make medicines affordable and accessible to more people, which wasn't as emphasized 14 years ago.
7. Telemedicine and digital health: Telemedicine and digital health platforms have gained prominence, enabling remote consultations, monitoring, and data collection, providing new ways for patient engagement and research.
8. Collaboration: Collaborations between pharmaceutical companies, academic institutions, and startups have increased, fostering innovation and cross-disciplinary research.
9. Real-world evidence: Data from electronic health records are used to supplement clinical trial data, providing a more comprehensive understanding of drug effectiveness.
10. Patient-centric approach: The industry now places a stronger emphasis on patient-centric care and involving patients in clinical trial design and drug development, leading to more relevant and effective treatments.
11. Diversity and inclusion: Efforts to increase diversity and inclusion in clinical trials and research have grown, aiming to ensure that therapies are effective for a broader range of patients.
12. Environmental concerns: Sustainability and environmental impact considerations are gaining traction, leading to a push for greener manufacturing practices and reduced waste compared to 14 years ago.
13. Data privacy and ethics: Heightened awareness of data privacy and ethical concerns surrounding patient data usage and sharing has led to more stringent regulations and practices in handling sensitive information.
14. Patient education: Patient education and engagement are facilitated through online platforms and social media, empowering patients to take an active role in their healthcare.

Did I miss anything? Feel free to add in the comments!